$6.06
-0.04-0.66%
At Close: -
$6.06
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Skye Bioscience
SKYENASDAQ
Skye Bioscience (NASDAQ:SKYE) Stock, Analyst Ratings, Price Targets, Forecasts
Skye Bioscience Inc has a consensus price target of $19.25 based on the ratings of 4 analysts. The high is $25 issued by Oppenheimer on April 12, 2024. The low is $14 issued by Cantor Fitzgerald on July 1, 2024. The 3 most-recent analyst ratings were released by Craig-Hallum, Cantor Fitzgerald, and Cantor Fitzgerald on July 9, 2024, July 1, 2024, and June 18, 2024, respectively. With an average price target of $15.33 between Craig-Hallum, Cantor Fitzgerald, and Cantor Fitzgerald, there's an implied 153.03% upside for Skye Bioscience Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Craig-Hallum
Cantor Fitzgerald
Oppenheimer
Piper Sandler
1calculated from analyst ratings
Analyst Ratings for Skye Bioscience
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/09/2024 | Buy Now | 197.03% | Craig-Hallum | Albert Lowe | → $18 | Initiates | → Buy | Get Alert |
| 07/01/2024 | Buy Now | 131.02% | Cantor Fitzgerald | Kristen Kluska | $14 → $14 | Reiterates | Overweight → Overweight | Get Alert |
| 06/18/2024 | Buy Now | 131.02% | Cantor Fitzgerald | Kristen Kluska | $14 → $14 | Reiterates | Overweight → Overweight | Get Alert |
| 06/17/2024 | Buy Now | 131.02% | Cantor Fitzgerald | Kristen Kluska | $14 → $14 | Reiterates | Overweight → Overweight | Get Alert |
| 05/23/2024 | Buy Now | 246.53% | Cantor Fitzgerald | Kristen Kluska | → $21 | Initiates | → Overweight | Get Alert |
| 04/12/2024 | Buy Now | 312.54% | Oppenheimer | Jay Olson | → $25 | Initiates | → Outperform | Get Alert |
| 03/14/2024 | Buy Now | 230.03% | Piper Sandler | Edward Tenthoff | $12 → $20 | Reiterates | Overweight → Overweight | Get Alert |
| 02/05/2024 | Buy Now | 98.02% | Piper Sandler | Edward Tenthoff | → $12 | Initiates | → Overweight | Get Alert |
FAQ
What is the target price for Skye Bioscience (SKYE) stock?
The latest price target for Skye Bioscience (NASDAQ:SKYE) was reported by Craig-Hallum on July 9, 2024. The analyst firm set a price target for $18.00 expecting SKYE to rise to within 12 months (a possible 197.03% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Skye Bioscience (SKYE)?
The latest analyst rating for Skye Bioscience (NASDAQ:SKYE) was provided by Craig-Hallum, and Skye Bioscience initiated their buy rating.
When was the last upgrade for Skye Bioscience (SKYE)?
There is no last upgrade for Skye Bioscience
When was the last downgrade for Skye Bioscience (SKYE)?
There is no last downgrade for Skye Bioscience.
When is the next analyst rating going to be posted or updated for Skye Bioscience (SKYE)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Skye Bioscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Skye Bioscience was filed on July 9, 2024 so you should expect the next rating to be made available sometime around July 9, 2025.
Is the Analyst Rating Skye Bioscience (SKYE) correct?
While ratings are subjective and will change, the latest Skye Bioscience (SKYE) rating was a initiated with a price target of $0.00 to $18.00. The current price Skye Bioscience (SKYE) is trading at is $6.06, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.